Biotech Stocks

Biotech Stocks
Source: ©iStock.com/AlexRaths
Biotechnology has been one of the fastest advancing industries in the past decade. With new medicine always being synthesized and new ways to fertilize crops, the sector is diverse and prosperous, especially as corporations look for new findings or better efficiency. Subsequently, the biotech stocks are booming and should continue to rise in the future.
Some of the best biotech stocks to buy in 2014 include Amgen (NYSE:AMGN) and Gilead Sciences (NYSE:GILD) although many smaller biotech corporations are on the rise and worth a consideration. Biotech stocks can cure your ailing portfolio and lead you down the road to recovery.

Biotechnology Sector Quote (CIX: MSECTOR5151)

Recent Articles

5 Top Biotech Stocks to Buy on Trump Victory

The case for buying biotech stocks has strengthened following the election of Donald Trump to the White House. More 

This Unlucky Biotech Stock Has Entered The Value-Buy Zone (OPHT)

The volatility of biotech shares makes biotech investing among the most lucrative ways to invest. Here's a great way to start... More 

Avoid These 7 Big-Name Biotechs and Pharmaceuticals

Biotech and pharmaceutical companies headed lower and not because of the election. Here's why you should sell these stocks More 

The iShares Nasdaq Biotechnology Index (ETF) (IBB) Is at a Critical Level

The iShares Nasdaq Biotechnology ETF (IBB) has dwindled over the past few weeks. Now, it's on a hair-thin line of support that bulls and bears alike should watch. More 

Celgene Corporation (CELG) – Two Ways to Trade CELG Stock

CELG stock now sits at a critical technical juncture with two paths to take after Celgene experienced a wild ride in late July and August. More 

The iShares Nasdaq Biotechnology Index (ETF) (IBB) Is on Breakout Watch!

The iShares Nasdaq Biotechnology ETF (IBB) has settled into a constructive-looking phase. The path of least resistance? North! More 

The iShares Nasdaq Biotechnology Index (ETF) (IBB) — It’s Make-or-Break Time

While the intermediate-term trend remains intact for the IBB etf, earnings season for large biotech companies could be make-or-break. More 

The iShares Nasdaq Biotechnology Index (ETF) (IBB): Gravity Calls!

Active investors and traders should look to play the iShares Nasdaq Biotechnology Index (ETF) (IBB) to the short side until the picture changes. More 

ABBV Stock: Could AbbVie Inc’s Gamble on Stemcentrx Pay Off?

Stemcentrx's acquisition does little to alleviate the risk of the potential decrease in sales once Humira loses patent protection. More 

3 Tips To Find Winning Biotech Stocks

Finding biotech stocks to invest in involves some level of danger. Use these tips to help determine your best bets, and start with these 3 biotechs to buy More